您的位置: 首页 > 农业专利 > 详情页

COMPOSITION MÉDICALE DESTINÉE À PROMOUVOIR LA FIBRINOLYSE
专利权人:
Limited;Daiichi Sankyo Company
发明人:
FURUGORI, Taketoshi,MORISHIMA, Yoshiyuki
申请号:
EP15873246
公开号:
EP3238721A4
申请日:
2015.12.25
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
It is intended to provide a novel pharmaceutical composition that can promote fibrinolysis. The present invention provides a pharmaceutical composition for the promotion of fibrinolysis, comprising edoxaban or a pharmaceutically acceptable salt thereof, or a hydrate of the compound or the salt. The present invention further provides a pharmaceutical composition for the promotion of fibrinolysis, comprising edoxaban or a pharmaceutically acceptable salt thereof, or a hydrate of the compound or the salt and further comprising a TAFIa inhibitor.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充